Nuclear‐targeting Peptides for Cancer Therapy

Nucleus is the central regulator of cells that controls cell proliferation, metabolism, and cell cycle, and is considered the most important organelle in cells. The precision medicine that can achieve nuclear targeting has achieved good therapeutic effects in anti‐tumor therapy. However, the presence of biological barriers such as cell membranes and nuclear membranes in cells limit the delivery of therapeutic agents to the nucleus. Therefore, developing effective nuclear‐targeting drug delivery strategies is particularly important. Nuclear‐targeting peptides are a class of functional peptides that can penetrate cell membranes and target the nucleus. They mainly recognize and bind to the nuclear transport molecules (such as Importin‐α/β) and transport the therapeutic agents to the nucleus through nuclear pore complexes (NPC). This review summarizes the most recent developments of strategies for anti‐tumor therapy utilizing nuclear‐targeting peptides, which will ultimately contribute to the development of more effective nuclear‐targeting strategies to achieve better anti‐tumor outcomes.